Effect and mechanism of perioperative rehabilitation on patients undergoing elective cardiac valve surgery

Conditions

Heart surgery-related diseases

Wei Huang, Yuqiang Wang, Zeruxin Luo, Xiu Zhang, Mengxuan Yang et al. (8 authors)

Reviews in Cardiovascular Medicine2024-09-10

An Accessible Pre-Rehabilitation Bundle for Patients Undergoing Elective Heart Valve Surgery with Limited Resources: The TIME Randomized Clinical Trial

Zeruxin Luo, Xiu Zhang, Yuqiang Wang, Wei Huang, Miao Chen et al. (7 authors)

Reviews in Cardiovascular Medicine2023-11-099 citations

10.31083/j.rcm2411308

RETRACTED: Postoperative Pulmonary Complications in Patients With Transcatheter Tricuspid Valve Implantation—Implications for Physiotherapists

Pengming Yu, Yuqiang Wang, Ze-Ruxing Luo, Raymond C. C. Tsang, Oystein Tronstad et al. (8 authors)

Frontiers in Cardiovascular Medicine2022-05-195 citations

10.3389/fcvm.2022.904961

Interventions

Rehabilitation group :(sputum removal training, breathing training, aerobic training, grip strength training, resistance training)

Control group :Traditional perioperative care

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective median sternotomy or cardiac intervention for the first time; 2. Aged 18 to 90 years old; 3. 8 hours after admission, without chest pain, dyspnea or other discomfort; 4. Troponin level did not increase further; 5. There are no new signs of heart failure decompensation (dyspnea with wet rales at rest); 6. No new obvious arrhythmia or dynamic changes of ECG in the past 8 hours; 7. Resting heart rate of 50-100 times/min; 8. Resting blood pressure 90~160/60~120mmHg; 9. SpO2 > 95%; 10. No history of mental illness and other serious acute or chronic diseases; 11. Informed consent and signed an agreement to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Uncontrolled unstable angina pectoris; 2. Uncontrolled severe arrhythmia that causes symptoms or hemodynamic disorders; 3. Acute endocarditis; 4. Acute myocarditis or pericarditis; 5. Acute aortic dissection; 6. Severe motor dysfunction; 7. Recent (6 months) stroke or transient ischemic attack; 8. Patients who do not cooperate or cannot communicate; 9. Combined with severe physical diseases and uncorrected clinical conditions (such as severe anemia, electrolyte imbalance and hyperthyroidism); 10. Participate in other clinical trials at the same time; 11. Patients with second surgery; 12. The expected survival time is less than 24 hours.

Design outcomes

Primary

Measure	Time frame
6-minute walk test (steps, oxygen saturation, heart rate, Borg score, RPE rating);postoperative pulmonary complications;Respiratory muscle function (MIP, MEP, FEV1, FEV1%, FVC, MVV);	—

Secondary

Measure	Time frame
Quality of Life MBI Index;Anxiety SAS score;Depression SDS score;Intensive care unit stay time;Mental consciousness (CAM-ICU, RASS);	—

Countries

China

Contacts

Public ContactPengming Yu

West China Hospital of Sichuan University

13438201451@126.com+86 13438201451

Outcome results

None listed